No­vavax and Gavi set­tle over Covid-19 vac­cine part­ner­ship dis­pute 

No­vavax and Gavi, the Vac­cine Al­liance, have reached a set­tle­ment on their part­ner­ship dis­agree­ment, with the vac­cine man­u­fac­tur­er hand­ing Gavi a to­tal of $400 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.